Video
At the upcoming Probiotic, Prebiotic and New Food Congress, Professor Willem de Vos, University of Helsinki, will explore emerging insights into the role of dietary fibers and their transformation into…
At the upcoming 13th edition of the Probiotics, Prebiotics, and New Food Congress in Rome, Professor Emma Allen-Vercoe, PhD from the University of Guelph (Canada), will present groundbreaking research on…
Professor Jacques Ravel, from University of Maryland School of Medicine and LUCA Biologics, discusses his latest research and therapeutic innovations in the field of vaginal microbiome modulation.
Celine Druart, from the Pharmabiotic Research Institute, discusses the new European regulation concerning substances of human origin and the impact on microbiome research and therapeutic development.
Matthew Cheng, CEO of Kanvas Biosciences, introduces the company’s cutting-edge spatial biology platform, developed to provide deeper insights into host-microbiome interactions.
Maitrayee Chatterjee, Ph.D., Project Manager and Senior Scientist at InnoGI Technologies, discusses their innovative and non-invasive platform to mimic both the upper and lower gastrointestinal tract, offering precise and standardized…
Emil Chuang, Chief Medical Officer at Intrinsic Medicine, explores the growing understanding of gut-brain axis disorders and the potential of Human Milk Oligosaccharides (HMOs) in their treatment.
David Paez-Espino, Co-founder & CTO at Ancilia Biosciences, discusses the use of CRISPR technology to develop a new class of bacterial therapies that address critical gaps in microbiome-based treatments.
Chris Ford, Senior Vice President, Translational Biology at Seres Therapeutics, discusses the development of SER-155, a cultivated bacterial consortium designed to address the unmet medical need of preventing bloodstream infections…
The discussion with Professor Alessio Fasano highlights the complex interplay between homeostatic, hedonic, and microbiota-driven mechanisms in regulating hunger.
